AstroNova Reports Financial Results for the Third Quarter of Fiscal 2022

12/08/2021

Continued Recovery of Commercial Air Travel Drives 35% YoY Increase in Test & Measurement Revenue

Third-Quarter Fiscal 2022 Summary

  • Bookings of $32.3 million, up 16% year-over-year
  • Revenue of $28.9 million, up 3% year-over-year
  • Backlog of $26.8 million, up 16% year-over-year
  • GAAP operating income of $0.3 million
  • GAAP net loss of $0.4 million, or $0.06 per share, which includes costs associated with the write-off of the Company’s legacy enterprise resource planning (ERP) system
  • Non-GAAP net income of $0.1 million, or $0.01 per diluted share, excluding ERP write-off costs
  • Adjusted EBITDA of $1.1 million excluding ERP write-off costs, or 3.8% of revenue
  • Company expects sequential and year-over-year top-line growth in the fourth quarter of FY 2022

WEST WARWICK, R.I.--(BUSINESS WIRE)-- AstroNova, Inc. (NASDAQ: ALOT), a global leader in data visualization technologies, today announced financial results for the fiscal 2022 third quarter ended October 30, 2021.

CEO Commentary

Gregory A. Woods, AstroNova’s President and Chief Executive Officer, stated, “Orders were strong again this quarter, as demand for our products continued to expand. Although sales were somewhat hampered by supply chain challenges affecting both segments of our business, total revenue nevertheless increased 3% year-over-year, as the ongoing recovery of the commercial aviation market helped drive double-digit growth in our Test & Measurement segment. In the Product Identification segment, in-person tradeshow activity continued to pick up in the quarter, as we demonstrated our latest printing and labeling products at major industry events including PACK EXPO in the U.S. and FACHPACK, the European trade fair for packaging, technology and processing.

Business Outlook

“Third-quarter bookings increased 16% to $32.3 million, highlighting strong demand trends heading into the final quarter of the year,” Woods continued. “Based on these trends and our expanding backlog, we believe we are well positioned for sequential and year-over-year growth in the fourth quarter of fiscal 2022.”

Q3 FY 2022 Operating Segment Results

Product Identification segment revenue in the third quarter of fiscal 2022 was $21.9 million compared with $22.9 million in the same period of fiscal 2021. Segment operating income was $1.8 million, or 8.3% of revenue, compared with $3.5 million, or 15.4% of revenue, in the prior year.

Test & Measurement segment revenue in the third quarter of fiscal 2022 increased 35.4% to $6.9 million from $5.1 million in the same period of fiscal 2021. The Test & Measurement segment recorded operating income of $0.8 million, or 12.2% of revenue, compared with a segment operating loss of $0.8 million, or a loss of 14.7% of revenue, in the comparable period of fiscal 2021.

Q3 FY 2022 Results Summary

Revenue for the third quarter of fiscal 2022 totaled $28.9 million, up 3.0% compared with $28.0 million in the year-earlier period.

Gross profit for the third quarter of fiscal 2022 was $10.4 million, or 36.0% of revenue, compared with $9.7 million, or 34.7% of revenue, in the same period of fiscal 2021. The increase compared with the same quarter last year reflects higher revenue and the impact of favorable product mix.

Operating expenses for the third quarter of fiscal 2022 totaled $10.1 million, compared with $9.3 million in the third quarter fiscal 2021, primarily reflecting investments in Research & Development and marketing expenses to support the business.

On a GAAP basis, AstroNova reported a net loss of $425,000, or $0.06 per share, which includes costs of $0.5 million (after-tax) associated with the write-off of the Company’s legacy enterprise resource planning (ERP) system. During the quarter, AstroNova completed the initial transition to a new global ERP system. On a non-GAAP basis, excluding the ERP write-off, net income was $0.1 million, or $0.01 per diluted share, in the third quarter of fiscal 2022. Net income for the third quarter of fiscal 2021 was $12,000, or $0.00 per share.

Earnings before interest, taxes, depreciation and amortization (EBITDA) was $0.3 million for the third quarter of fiscal 2022, compared with $1.7 million for the same period in fiscal 2021. Third-quarter fiscal 2022 EBITDA, excluding ERP write-off costs, was $0.7 million, or 2.4% of revenue.

Adjusted EBITDA, which is EBITDA further adjusted for share-based compensation, was $0.7 million, or 2.5% of revenue, and $1.1 million, or 3.8% of revenue, excluding ERP write-off costs. This compares with Adjusted EBITDA of $2.3 million, or 8.2% of revenue, in the same period of the prior year.

Non-GAAP net income, non-GAAP earnings per diluted share, EBITDA, EBITDA excluding ERP write-off costs, EBITDA excluding ERP write-off costs and CARES Act benefits, Adjusted EBITDA, Adjusted EBITDA excluding ERP write-off costs, and Adjusted EBITDA excluding ERP write-off costs and CARES Act benefits are non-GAAP financial measures explained in greater detail below under “Use of Non-GAAP Financial Measures.” Please refer to the financial reconciliation table included in this news release for a reconciliation of non-GAAP measures to the closest comparable GAAP measures for the fiscal third quarter and nine months ended October 30, 2021 and October 31, 2020.

Bookings for the third quarter of fiscal 2022 were $32.3 million, compared with $27.9 million in the third quarter of fiscal 2021.

Backlog at October 30, 2021 was $26.8 million versus $23.2 million as of October 31, 2020.

Third-Quarter Fiscal 2022 Conference Call

AstroNova will discuss its third-quarter fiscal 2022 financial results in an investor conference call at 9:00 a.m. ET today. To participate on the conference call, please dial (800) 430-8332 (U.S. and Canada) or (773) 341-1662 (International) approximately 10 minutes prior to the start time and enter confirmation code 3080960.

You can hear a replay of the conference call from 12:00 p.m. ET Wednesday, December 8, 2021 until 12:00 p.m. ET Wednesday, December 15, 2021 by dialing (888) 203-1112 (U.S. and Canada) or (719) 457-0820 (International). The passcode is 3080960. A real-time and an archived audio webcast of the call will be available through the “Investors” section of the AstroNova website, https://investors.astronovainc.com.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures: non-GAAP net income, non-GAAP net income per diluted share, non-GAAP gross profit, non-GAAP operating expenses, non-GAAP segment operating income, earnings before interest, taxes, depreciation and amortization (EBITDA), EBITDA excluding ERP write-off costs and CARES Act benefits, Adjusted EBITDA, and Adjusted EBITDA excluding ERP write-off costs and CARES Act benefits. AstroNova believes that the inclusion of these non-GAAP financial measures helps investors gain a meaningful understanding of changes in the Company's core operating results, and can help investors who wish to make comparisons between AstroNova and other companies on both a GAAP and a non-GAAP basis. AstroNova’s management uses these measures, in addition to GAAP financial measures, as the basis for measuring its core operating performance and comparing such performance to that of prior periods and to the performance of its competitors. These measures also are used by the Company’s management to assist with their financial and operating decision-making.

About AstroNova

AstroNova, Inc. (NASDAQ: ALOT), a global leader in data visualization technologies since 1969, is focused on designing, manufacturing, distributing and servicing a broad range of products that acquire, store, analyze and present data in multiple formats. The Company's Product Identification segment offers a complete line-up of label and direct-to-package printing hardware and supplies, allowing customers to mark, track and enhance their products' appearance. Supported by AstroNova's customer application experts and technology leadership in printing, material science and high-speed data processing, customers benefit from an optimized, "total solution" approach. The Test and Measurement segment includes the AstroNova Aerospace business unit. This segment designs and manufactures flight deck printers, networking hardware and related accessories serving the world's aerospace and defense industries with proven advanced airborne technology solutions for the cockpit, the cabin and so much more. AstroNova is a member of the Russell Microcap® Index and the LD Micro Index (INDEXNYSEGIS: LDMICRO). Additional information is available by visiting www.astronovainc.com. 

Forward-Looking Statements

Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended January 31, 2021 and subsequent filings AstroNova makes with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The reader is cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in this news release.

ASTRONOVA, INC.

Condensed Consolidated Statements of Income

In Thousands Except for Per Share Data

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

 

October 31, 2020

 

October 30, 2021

 

October 31, 2020

Revenue

$

28,857

 

$

28,017

 

$

87,780

 

$

86,595

 

Cost of Revenue

 

18,472

 

 

18,282

 

 

53,792

 

 

56,218

 

Gross Profit

 

10,385

 

 

9,735

 

 

33,988

 

 

30,377

 

Total Gross Profit Margin

 

36.0

%

 

34.7

%

 

38.7

%

 

35.1

%

Operating Expenses:
Selling & Marketing

 

5,777

 

 

5,553

 

 

16,931

 

 

17,033

 

Research & Development

 

1,948

 

 

1,412

 

 

5,203

 

 

4,845

 

General & Administrative

 

2,364

 

 

2,353

 

 

7,372

 

 

7,214

 

Total Operating Expenses

 

10,089

 

 

9,318

 

 

29,506

 

 

29,092

 

Operating Income

 

296

 

 

417

 

 

4,482

 

 

1,285

 

Total Operating Margin

 

1.0

%

 

1.5

%

 

5.1

%

 

1.5

%

Other Income (Expense), net:
Extinguishment of Debt - PPP Loan

 

-

 

 

-

 

 

4,466

 

 

-

 

Loss on Disposal of Assets

 

(696

)

 

-

 

 

(696

)

 

-

 

Interest Expense

 

(135

)

 

(286

)

 

(526

)

 

(776

)

Gain (Loss) on Foreign Currency Transactions

 

(117

)

 

(85

)

 

(231

)

 

314

 

Other, net

 

53

 

 

(66

)

 

(11

)

 

3

 

 

(895

)

 

(437

)

 

3,002

 

 

(459

)

 
Income (Loss) Before Taxes

 

(599

)

 

(20

)

 

7,484

 

 

826

 

Income Tax (Benefit) Provision

 

(174

)

 

(32

)

 

297

 

 

379

 

Net Income (Loss)

$

(425

)

$

12

 

$

7,187

 

$

447

 

Net Income (Loss) per Common Share - Basic

$

(0.06

)

$

0.00

 

$

1.00

 

$

0.06

 

Net Income (Loss) per Common Share - Diluted

$

(0.06

)

$

0.00

 

$

0.98

 

$

0.06

 

 
Weighted Average Number of Common Shares - Basic

 

7,234

 

 

7,120

 

 

7,196

 

 

7,100

 

Weighted Average Number of Common Shares - Diluted

 

7,234

 

 

7,185

 

 

7,325

 

 

7,137

 

 
ASTRONOVA, INC.

Balance Sheet

In Thousands

(Unaudited)

 

October 30, 2021

January 31, 2021

 
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents

$

8,727

$

11,439

Accounts Receivable, net

 

16,351

 

17,415

Inventories, net

 

31,661

 

30,060

Prepaid Expenses and Other Current Assets

 

6,451

 

1,807

Total Current Assets

 

63,190

 

60,721

PROPERTY, PLANT AND EQUIPMENT

 

50,624

 

50,839

Less Accumulated Depreciation

 

(38,950)

 

(38,828)

Property, Plant and Equipment, net

 

11,674

 

12,011

OTHER ASSETS
Intangible Assets, net

 

19,637

 

21,502

Goodwill

 

12,415

 

12,806

Deferred Tax Assets

 

5,942

 

5,941

Right of Use Asset

 

1,106

 

1,389

Other Assets

 

1,658

 

1,103

TOTAL ASSETS

$

115,622

$

115,473

LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts Payable

$

6,866

$

5,734

Accrued Compensation

 

4,370

 

2,852

Other Liabilities and Accrued Expenses

 

3,835

 

3,939

Current Portion of Royalty Obligation

 

2,000

 

2,000

Current Portion of Long-Term Debt

 

938

 

5,326

Current Liability – Excess Royalty Payment Due

 

220

 

177

Deferred Revenue

 

284

 

285

Income Taxes Payable

 

-

 

655

Total Current Liabilities

 

18,513

 

20,968

NON-CURRENT LIABILITIES
Long-Term Debt, net of current portion

 

8,397

 

7,109

Royalty Obligation, net of current portion

 

4,811

 

6,161

Long-Term Debt - PPP Loan

 

-

 

4,422

Lease Liability, net of current portion

 

826

 

1,065

Other Long-Term Liabilities

 

557

 

681

Deferred Tax Liabilities

 

336

 

384

TOTAL LIABILITIES

 

33,440

 

40,790

SHAREHOLDERS’ EQUITY
Common Stock

 

528

 

521

Additional Paid-in Capital

 

59,502

 

58,049

Retained Earnings

 

57,272

 

50,085

Treasury Stock

 

(33,944)

 

(33,588)

Accumulated Other Comprehensive Loss, net of tax

 

(1,176)

 

(384)

TOTAL SHAREHOLDERS’ EQUITY

 

82,182

 

74,683

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

$

115,622

$

115,473

 
ASTRONOVA, INC.

Revenue and Segment Operating Profit (Loss)

In Thousands

(Unaudited)

 

Revenue

Segment Operating Profit (Loss)

Revenue

Segment Operating Profit (Loss)

Three Months Ended

Three Months Ended

Nine Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Product Identification

$

21,928

$

22,898

$

1,818

 

$

3,521

 

$

68,519

$

66,907

$

8,952

$

9,813

 

Test & Measurement

 

6,929

 

5,119

 

842

 

 

(751

)

 

19,261

 

19,688

 

2,902

 

(1,314

)

Total

$

28,857

$

28,017

 

2,660

 

 

2,770

 

$

87,780

$

86,595

 

11,854

 

8,499

 

Corporate Expenses

 

2,364

 

 

2,353

 

 

7,372

 

7,214

 

Operating Income

 

296

 

 

417

 

 

4,482

 

1,285

 

Other Income (Expense), net

 

(895

)

 

(437

)

 

3,002

 

(459

)

Income (Loss) Before Income Taxes

 

(599

)

 

(20

)

 

7,484

 

826

 

Income Tax (Benefit) Provision

 

(174

)

 

(32

)

 

297

 

379

 

Net Income (Loss)

$

(425

)

$

12

 

$

7,187

$

447

 

 
ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP - Gross Profit

Amounts in Thousands

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Gross Profit − GAAP

$

10,385

$

9,735

$

33,988

 

$

30,377

 
Employee Retention Credit, net

 

-

 

-

 

(1,641

)

 

-

 
Gross Profit − Non-GAAP

$

10,385

$

9,735

$

32,347

 

$

30,377

 
ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP - Operating Expenses

Amounts in Thousands

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Operating Expenses − GAAP

$

10,089

$

9,318

$

29,506

$

29,092

 
Employee Retention Credit, net

 

-

 

-

 

489

 

-

 
Operating Expenses − Non-GAAP

$

10,089

$

9,318

$

29,995

$

29,092

ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP - Operating Income

Amounts in Thousands

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Operating Income − GAAP

$

296

$

417

$

4,482

 

$

1,285

 
Employee Retention Credit, net

 

-

 

-

 

(2,130

)

 

-

 
Operating Income − Non-GAAP

$

296

$

417

$

2,352

 

$

1,285

 
ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP - Net Income (Loss)

Amounts in Thousands

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Net Income (Loss) − GAAP

$

(425

)

$

12

$

7,187

 

$

447

 
Oracle EnterpriseOne ERP Write-off

$

528

 

 

-

$

528

 

 

-

 
Employee Retention Credit, net

 

-

 

 

-

 

(1,615

)

 

-

 
PPP Loan Forgiveness

 

-

 

 

-

 

(4,426

)

 

-

 
Net Income (Loss) − Non-GAAP

$

103

 

$

12

$

1,674

 

$

447

 
ASTRONOVA, INC.

Reconciliation of GAAP to Non-GAAP - Diluted Earnings Per Share

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Diluted Earnings Per Share − GAAP

$

(0.06

)

$

0.00

$

0.98

 

$

0.06

 
Oracle EnterpriseOne ERP Write-off

 

0.07

 

 

-

 

0.07

 

 

-

 
Employee Retention Credit, net

 

-

 

 

-

 

(0.22

)

 

-

 
PPP Loan Forgiveness

 

-

 

 

-

 

(0.60

)

 

-

 
Diluted Earnings Per Share − Non-GAAP

$

0.01

 

$

0.00

$

0.23

 

$

0.06

 
ASTRONOVA, INC.

Reconciliation of Net Income to EBITDA

Amounts in Thousands

(Unaudited)

   

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Net Income − GAAP

$

(425

)

$

12

 

$

7,187

 

$

447

Interest Expense

 

135

 

 

286

 

 

526

 

 

776

Income Tax Expense (Provision)

 

(174

)

 

(32

)

 

297

 

 

379

Depreciation/Amortization

 

796

 

 

1,438

 

 

3,070

 

 

4,571

EBITDA

$

332

 

$

1,704

 

$

11,080

 

$

6,173

Net Income - Employee Retention Credit

 

-

 

 

-

 

 

(1,615

)

 

-

Net Income - PPP Loan Forgiveness

 

-

 

 

-

 

 

(4,426

)

 

-

Net Income - Oracle EnterpriseOne ERP Write-off

 

528

 

 

-

 

 

528

 

-

Income Tax Expense - Employee Retention Credit

 

-

 

 

-

 

 

515

 

 

-

Income Tax Expense - PPP Loan Forgiveness

 

-

 

 

-

 

 

40

 

 

-

Income Tax Expense - Oracle EnterpriseOne ERP Write-off

 

(168

)

-

 

 

(168

)

-

EBITDA Excluding ERP Write-off and CARES Act Benefits

$

692

 

$

1,704

 

$

5,954

 

$

6,173

 
ASTRONOVA, INC.

Reconciliation of Net Income (Loss) to Adjusted EBITDA

Amounts in Thousands

(Unaudited)

   

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Net Income (Loss) − GAAP

$

(425

)

$

12

 

$

7,187

 

$

447

Interest Expense

 

135

 

 

286

 

 

526

 

 

776

Income Tax (Provision) Expense

 

(174

)

 

(32

)

 

297

 

 

379

Depreciation/Amortization

 

796

 

 

1,438

 

 

3,070

 

 

4,571

Share-Based Compensation

 

398

 

 

591

 

 

1,345

 

 

1,687

Adjusted EBITDA

$

730

 

$

2,295

 

$

12,425

 

$

7,860

Net Income - Employee Retention Credit

 

-

 

 

-

 

 

(1,615

)

 

-

Net Income - PPP Loan Forgiveness

 

-

 

 

-

 

 

(4,426

)

 

-

Net Income - Oracle EnterpriseOne ERP Write-off

 

528

 

-

 

 

528

 

-

Income Tax Expense - Employee Retention Credit

 

-

 

 

-

 

 

515

 

 

-

Income Tax Expense - PPP Loan Forgiveness

 

-

 

 

-

 

 

40

 

 

-

Income Tax Expense - Oracle EnterpriseOne ERP Write-off

 

(168

)

-

 

 

(168

)

-

Adjusted EBITDA Excluding ERP Write-off and CARES Act Benefits

$

1,090

 

$

2,295

 

$

7,299

 

$

7,860

 
ASTRONOVA, INC.

Reconciliation of Segment GAAP to Non-GAAP Operating Income (Loss)

Amounts in Thousands

(Unaudited)

 

Three Months Ended

Nine Months Ended

October 30, 2021

October 31, 2020

October 30, 2021

October 31, 2020

Product

Identification

Test &

Measurement

Total

Product

Identification

Test &

Measurement

Total

Product

Identification

Test &

Measurement

Total

Product

Identification

Test &

Measurement

Total

Segment Operating Profit (Loss) - GAAP

$

1,818

$

842

$

 

2,660

$

3,521

$

(751

)

$

 

2,770

$

8,952

 

$

2,902

 

$

 

11,854

 

$

9,813

$

(1,314

)

$

 

8,499

 
Employee Retention Credit, net

 

-

 

-

 

 

-

 

-

 

-

 

 

 

-

 

(1,430

)

 

(802

)

 

 

(2,232

)

 

-

 

-

 

 

 

-

 
Segment Operating Profit - Non-GAAP

$

1,818

$

842

$

 

2,660

$

3,521

$

(751

)

$

 

2,770

$

7,523

 

$

2,100

 

$

 

9,623

 

$

9,813

$

(1,314

)

$

 

8,499

 

Scott Solomon
Senior Vice President
Sharon Merrill Associates
(617) 542-5300
ALOT@investorrelations.com

Source: AstroNova, Inc.

IR Contact

AstroNova, Inc.
Investor Relations Department
600 East Greenwich Avenue
West Warwick, RI 02893
Scott Solomon
Senior Vice President Sharon Merrill
Phone: (617) 542-5300
Email: ALOT@investorrelations.com

Email Alerts

Email Address *

 
Enter the code shown above.

Interactive Analyst Center Disclaimer

The financial data and other material provided to users in the pages of the website is for information purposes only. Users should not rely on information on this website for any purpose other than for obtaining general knowledge of AstroNova. Material may be changed or updated without notice.

AstroNova, Inc.

Ok